Forfivo XL Approval History
- FDA approved: Yes (First approved November 10th, 2011)
- Brand name: Forfivo XL
- Generic name: bupropion hydrochloride
- Dosage form: Extended Release Tablets
- Company: IntelGenx Corp.
- Treatment for: Depression, Major Depressive Disorder
Forfivo XL (bupropion) is a high-strength formulation of the aminoketone antidepressant bupropion (contained in Wellbutrin) indicated for the treatment of major depressive disorder.
Development History and FDA Approval Process for Forfivo XL
|Nov 11, 2011||IntelGenx Announces FDA Approval of its High Dose Anti-Depressant Forfivo XL|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.